Nuvectis Pharma, Inc. (NVCT) Tops Q1 EPS by 53c

Nuvectis Pharma, Inc. (NASDAQ: NVCT) reported Q1 EPS of $0.27, $0.53 better than the analyst estimate of ($0.26).

For earnings history and earnings-related data on Nuvectis Pharma, Inc. (NVCT) click here.

You May Also Be Interested In

• X Financial (XYF) Tops Q2 EPS by 438c
• Amarin to present REDUCE-IT analyses at ESC Congress 2026
• AEG and Archer plan first downtown Los Angeles vertiport at L.A. LIVE